“`html
Amissa Redefines Menopause Care with AI-Powered Platform
Amissa, a Charlotte, North Carolina-based company, is leveraging artificial intelligence to improve the way menopause is understood and managed. As a recipient of a National Institutes of Health (NIH) Small Business Innovation Research grant NIH, Amissa provides a platform that aggregates data from multiple sources to deliver actionable insights to clinicians, ultimately enhancing patient care.
Understanding the Need for Improved Menopause Care
Menopause and perimenopause, the transition period leading up to menopause, are often poorly understood and inadequately addressed in customary healthcare settings.Women can begin experiencing perimenopause as early as their mid-30s Mayo Clinic, and the symptoms-which extend far beyond hot flashes-can be subtle and easily overlooked. Early symptoms frequently include anxiety, mood swings, and other changes that may not be immediately associated with hormonal shifts.
“You can experience symptoms for up to 10 years through this whole journey,” explains Samantha Smith, co-founder and CEO of Amissa. “Existing electronic Health Records (EHRs) frequently enough lack the necessary fields to track these symptoms effectively over time, hindering a clinician’s ability to provide personalized and informed care.”